{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:57:36Z","timestamp":1794869856617,"version":"4.9.1"},"reference-count":60,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ferring Pharmaceuticals"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01058"],"award-info":[{"award-number":["2020-01058"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,3,16]]},"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infections (CDIs) are associated with antibiotic use, although the link with other drugs remains underexplored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the association between antibiotic and non-antibiotic drugs with microbiome-modulating activity on new occurrences of CDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We conducted a Swedish population-based case\u2013control study from 2006 to 2019 including 42\u2009921 cases matched with 355\u2009159 population controls on age and sex, obtained from multiple linked Swedish registries. The effect of antibiotic and non-antibiotic use within 30 days from the index date on CDI occurrence was estimated using multivariable conditional logistic regression additionally with a lasso penalty. Models were adjusted for age and sex by design and for Charlson Comorbidity Index and concomitant drug use, providing adjusted ORs (aORs) with 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Antibiotics with the greatest CDI risk were lincosamides (aOR=31.4, 95% CI 27.9 to 35.3), combinations of penicillins (aOR=19.8, 95% CI 15.9 to 24.5), sulfonamides and trimethoprim, and cephalosporins, though no association for tetracyclines. Among non-antibiotic drugs, we found decreased risks of CDI for lipid-modifiers (aOR=0.8, 95% CI 0.8 to 0.8) and aspirin (aOR=0.8, 95% CI 0.7 to 0.8) and increased risks for antidiarrhoeals (aOR=7.3, 95% CI 6.8 to 7.8), corticosteroids (aOR=2.4, 95% CI 2.3 to 2.5), proton-pump inhibitors (PPIs) (aOR=1.8, 95% CI 1.7 to 1.8), nervous system drugs, constipation drugs, histamine H2-receptor antagonists, antidepressants, and beta blockers, but no significant risk for non-steroidal anti-inflammatory drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found varying effects of antibiotics on CDI, providing evidence for ongoing efforts in prudent prescribing decisions and antimicrobial stewardship. We confirmed PPI as a main risk factor for CDI and provided new evidence for other non-antibiotic drugs as potentially important risk factors considering their high prescription prevalence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-337629","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:20:26Z","timestamp":1774977626000},"page":"2215-2224","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Commonly prescribed drugs as risk factors for\n                    <i>Clostridioides difficile<\/i>\n                    infections: a Swedish population-based case\u2013control study"],"prefix":"10.1136","volume":"75","author":[{"given":"Annelies","family":"Boven","sequence":"first","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Global Health Institute, Department of Family Medicine and Population Health, Antwerp University, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Vranken","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Global Health Institute, Department of Family Medicine and Population Health, Antwerp University, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Vlieghe","sequence":"additional","affiliation":[{"name":"Global Health Institute, Department of Family Medicine and Population Health, Antwerp University, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4495-5880","authenticated-orcid":false,"given":"Annemarie","family":"Boleij","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fall","sequence":"additional","affiliation":[{"name":"School of Health and Medical Sciences, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7713-2373","authenticated-orcid":false,"given":"Lars","family":"Engstrand","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-447X","authenticated-orcid":false,"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Global Health Institute, Department of Family Medicine and Population Health, Antwerp University, Antwerp, Belgium"},{"name":"Department of Public Health and Primary Care, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026100702350691000_75.11.2215.1","unstructured":"Sikora A , Zahra F . Nosocomial infections statpearls. Treasure Island (FL): StatPearls Publishing; 2023. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559312\/ [Accessed 04 Nov 2023]."},{"key":"2026100702350691000_75.11.2215.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2016.05.009"},{"key":"2026100702350691000_75.11.2215.3","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1966277","article-title":"Updating changes in human gut microbial communities associated with Clostridioides difficile infection","volume":"13","author":"Herrera","year":"2021","journal-title":"Gut Microbes"},{"key":"2026100702350691000_75.11.2215.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03539-6"},{"key":"2026100702350691000_75.11.2215.5","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.07.010417","article-title":"Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis","volume":"7","author":"Eze","year":"2017","journal-title":"J Glob Health"},{"key":"2026100702350691000_75.11.2215.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113323","article-title":"Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers","volume":"23","author":"Piccioni","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026100702350691000_75.11.2215.7","doi-asserted-by":"crossref","first-page":"100642","DOI":"10.1016\/j.eclinm.2020.100642","article-title":"Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis","volume":"29\u201330","author":"Baunwall","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2026100702350691000_75.11.2215.8","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2106516"},{"key":"2026100702350691000_75.11.2215.9","first-page":"105","article-title":"Emerging Options for the Prevention and Management of Clostridioides difficile Infection","volume":"83","author":"Gonzales-Luna","year":"2023","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026100702350691000_75.11.2215.10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020426","article-title":"The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects","volume":"11","author":"Alshrari","year":"2023","journal-title":"Biomedicines"},{"key":"2026100702350691000_75.11.2215.11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3503"},{"key":"2026100702350691000_75.11.2215.12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich Vila","year":"2020","journal-title":"Nat Commun"},{"key":"2026100702350691000_75.11.2215.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat Commun"},{"key":"2026100702350691000_75.11.2215.14","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00541-25","article-title":"A hidden confounder for microbiome studies: medications used years before sample collection","volume":"10","author":"Aasmets","year":"2025","journal-title":"mSystems"},{"key":"2026100702350691000_75.11.2215.15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature New Biol"},{"key":"2026100702350691000_75.11.2215.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09364-3","article-title":"Clostridioides difficile infection, recurrence and the associated healthcare consumption in Sweden between 2006 and 2019: a population-based cohort study","volume":"24","author":"Boven","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026100702350691000_75.11.2215.17","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cmi.2023.07.008","article-title":"Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study","volume":"29","author":"Boven","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026100702350691000_75.11.2215.18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkae012","article-title":"The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence","volume":"79","author":"Moreels","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026100702350691000_75.11.2215.19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s15010-024-02193-1","article-title":"Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study","volume":"52","author":"Mpakaniye","year":"2024","journal-title":"Infection"},{"key":"2026100702350691000_75.11.2215.20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61602-x"},{"key":"2026100702350691000_75.11.2215.21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/EDE.0b013e31825fa528","article-title":"Prescription-drug-related risk in driving: comparing conventional and lasso shrinkage logistic regressions","volume":"23","author":"Avalos","year":"2012","journal-title":"Epidemiology"},{"key":"2026100702350691000_75.11.2215.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217057","article-title":"Penalized logistic regression with low prevalence exposures beyond high dimensional settings","volume":"14","author":"Doerken","year":"2019","journal-title":"PLoS ONE"},{"key":"2026100702350691000_75.11.2215.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.gloepi.2021.100062","article-title":"Population attributable fraction in textbooks: Time to revise","volume":"3","author":"Khosravi","year":"2021","journal-title":"Glob Epidemiol"},{"key":"2026100702350691000_75.11.2215.24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad413","article-title":"Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case\u2013Control Study","volume":"10","author":"Miller","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026100702350691000_75.11.2215.25","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/cid\/ciz978","article-title":"Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection","volume":"71","author":"White","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026100702350691000_75.11.2215.26","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2014.39"},{"key":"2026100702350691000_75.11.2215.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04037.x"},{"key":"2026100702350691000_75.11.2215.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.044"},{"key":"2026100702350691000_75.11.2215.29","doi-asserted-by":"crossref","unstructured":"Carlson TJ , Gonzales-Luna AJ , Wilcox MF , et al . Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use . Open Forum Infect Dis 2021;8. doi:10.1093\/ofid\/ofab419","DOI":"10.1093\/ofid\/ofab419"},{"key":"2026100702350691000_75.11.2215.30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/phar.1914","article-title":"Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients","volume":"37","author":"Scardina","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2026100702350691000_75.11.2215.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2014.07.010"},{"key":"2026100702350691000_75.11.2215.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71571-4"},{"key":"2026100702350691000_75.11.2215.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.04.005"},{"key":"2026100702350691000_75.11.2215.34","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06314"},{"key":"2026100702350691000_75.11.2215.35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ajic.2025.06.019","article-title":"Opioid use and risk of Clostridioides difficile infection in hospitalized patients: A systematic review and meta-analysis","volume":"53","author":"Gokhale","year":"2025","journal-title":"Am J Infect Control"},{"key":"2026100702350691000_75.11.2215.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106488"},{"key":"2026100702350691000_75.11.2215.37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40264-024-01502-9","article-title":"Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study","volume":"48","author":"Brusselaers","year":"2025","journal-title":"Drug Saf"},{"key":"2026100702350691000_75.11.2215.38","doi-asserted-by":"crossref","unstructured":"D\u2019Silva KM , Mehta R , Mitchell M , et al . Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clin Microbiol Infect 2021. doi:10.1016\/j.cmi.2021.01.008","DOI":"10.1016\/j.cmi.2021.01.008"},{"key":"2026100702350691000_75.11.2215.39","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i35.6500"},{"key":"2026100702350691000_75.11.2215.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056498","article-title":"The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis","volume":"8","author":"Tleyjeh","year":"2013","journal-title":"PLoS ONE"},{"key":"2026100702350691000_75.11.2215.41","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa353","article-title":"GABAergic but not Antidepressant Medications Increase Risk for Clostridioides difficile Infection in a National Cohort of Veterans","volume":"7","author":"Lalani","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026100702350691000_75.11.2215.42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.seizure.2010.12.011","article-title":"Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients","volume":"20","author":"Jahromi","year":"2011","journal-title":"Seizure"},{"key":"2026100702350691000_75.11.2215.43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/s0004-2803.230302023-21","article-title":"ANTIDEPRESSANT MEDICATIONS ARE ASSOCIATED WITH INCREASED RISK OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES DIFFICILE INFECTION: A POPULATION-BASED STUDY","volume":"60","author":"Boustany","year":"2023","journal-title":"Arq Gastroenterol"},{"key":"2026100702350691000_75.11.2215.44","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-121","article-title":"Depression, antidepressant medications, and risk of Clostridium difficile infection","volume":"11","author":"Rogers","year":"2013","journal-title":"BMC Med"},{"key":"2026100702350691000_75.11.2215.45","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.946601","article-title":"Clostridioides difficile and neurological disorders: New perspectives","volume":"16","author":"Biazzo","year":"2022","journal-title":"Front Neurosci"},{"key":"2026100702350691000_75.11.2215.46","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000189","article-title":"Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis","volume":"11","author":"Phatharacharukul","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"2026100702350691000_75.11.2215.47","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57090964","article-title":"The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis-A Real Life Cohort","volume":"57","author":"Girleanu","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2026100702350691000_75.11.2215.48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/ijmr.IJMR_1973_17","article-title":"Statins & risk of Clostridium difficile infection: A meta-analysis","volume":"150","author":"Wijarnpreecha","year":"2019","journal-title":"Indian J Med Res"},{"key":"2026100702350691000_75.11.2215.49","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa439.981","article-title":"791. Evaluation of NSAID Exposure as a Risk Factor for Clostridium difficile infection: A Propensity-Score-Matched Case-Control Study","volume":"7","author":"Ressler","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026100702350691000_75.11.2215.50","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7431838","article-title":"Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis","volume":"2016","author":"Permpalung","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2026100702350691000_75.11.2215.51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02176-12"},{"key":"2026100702350691000_75.11.2215.52","doi-asserted-by":"publisher","DOI":"10.1086\/521859"},{"key":"2026100702350691000_75.11.2215.53","doi-asserted-by":"crossref","unstructured":"Zhang J , Chen L , Gomez-Simmonds A , et al . Antibiotic-Specific Risk for Community-Acquired Clostridioides difficile Infection in the United States from 2008 to 2020 . Antimicrob Agents Chemother 2022;66. doi:10.1128\/aac.01129-22","DOI":"10.1128\/aac.01129-22"},{"key":"2026100702350691000_75.11.2215.54","unstructured":"National Institute for Health and Care Excellence (NICE) . Clostridium difficile infection: risk with broad-spectrum antibiotics."},{"key":"2026100702350691000_75.11.2215.55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.25252","article-title":"Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection","volume":"8","author":"Gilboa","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026100702350691000_75.11.2215.56","doi-asserted-by":"crossref","unstructured":"James G , Witten D , Hastie T , et al . An Introduction to Statistical Learning (Second Edition). 2nd edn. 2023.","DOI":"10.1007\/978-3-031-38747-0"},{"key":"2026100702350691000_75.11.2215.57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gtc.2019.04.002","article-title":"Prescribed Drugs and the Microbiome","volume":"48","author":"Brusselaers","year":"2019","journal-title":"Gastroenterol Clin North Am"},{"key":"2026100702350691000_75.11.2215.58","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1791677","article-title":"Long-term effects of antimicrobial drugs on the composition of the human gut microbiota","volume":"12","author":"Mulder","year":"2020","journal-title":"Gut Microbes"},{"key":"2026100702350691000_75.11.2215.59","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.88.1.15"},{"key":"2026100702350691000_75.11.2215.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.11.005"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-337629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:35:50Z","timestamp":1791365750000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-337629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/gutjnl-2025-337629"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-337629","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}